Companies can leverage Italbiotec for support in securing Research and Development (R&D) financial aid through funds and grants.
Italbiotec: A Year of Growth and Expansion
Italbiotec, a Milan-based benefit corporation, is set to experience significant growth in 2025. The company, which operates primarily in the life sciences, agro-food, and bioeconomy sectors, has announced plans to expand its presence both in Italy and abroad.
According to Diego Bosco, the CEO of Italbiotec, the year ahead will be marked by strengthened international activities, new strategic partnerships, investments in research and development (R&D), sustainability, digitalization, and a substantial focus on internal human resource development and attracting new talent.
The growth for Italbiotec is expected to come from external consolidation, with new acquisitions in Italy and abroad. The strategy includes approaching strategic bioeconomy markets and expanding the sustainable innovation ecosystem in life sciences, agro-food, and biotechnology. Italbiotec's industrial plan includes acquiring specialized R&D entities to build an integrated service platform.
In 2024, Italbiotec achieved a turnover of 2.2 million euros, a 55% increase from the previous year, and EBITDA grew to 674,000 euros, a 165% increase. The provisional first-half 2025 balance sheet shows Italbiotec continuing along the development path followed in recent years, with growth mainly thanks to increased technology transfer activities, consolidated academic and industrial partnerships, and a strengthened European position.
Italbiotec's core activities include innovation management. Techniques used in this process include technical analysis, business plans, sustainability studies, and scientific training. The company's services aim to assist businesses in their challenging journey towards research, development, and innovation.
In addition to its core services, Italbiotec also offers auditing and reporting services, ensuring financial control and correct management of funded projects. These services do not specify the geographical location of the businesses they assist.
Italbiotec's vision, according to Diego Bosco, generates real and lasting value for stakeholders, the territory, and the entire innovation ecosystem. The CEO believes that the opportunities offered by the bio-economic transition have allowed the company to invest wisely in high-impact, scientific, and industrial projects.
Looking forward, Italbiotec plans to expand its presence in Italy and abroad over the next five years, opening offices in Belgium, Switzerland, France, the United States, and the United Arab Emirates. The company's commitment to sustainability, innovation, and partnerships positions it well for continued growth and success in the years ahead.
- Italbiotec's growth strategy for 2025 includes expanding in the finance sector, as the company plans to invest significantly in research and development (R&D) and attract new talent, potentially appointing financial controllers for its upcoming operations in Belgium, Switzerland, France, the United States, and the United Arab Emirates.
- To fortify its international activities and create a sustainable innovation ecosystem, Italbiotec will engage in technology-intensive business activities, integrating digitalization in its operations and forging strategic partnerships, especially in the bio-economic markets, as it expands its presence in the technology sector.
%20financial%20aid%20through%20funds%20and%20grants.){kind=link}